open access
Vol 53, No 3 (2022)
Editorial
Submitted: 2022-05-23
Accepted: 2022-05-23
Get Citation
Editorial
Jan Styczyński1
DOI: 10.5603/AHP.2022.0017
·
Acta Haematol Pol 2022;53(3):151-152.
Affiliations- Department of Pediatric Hematology and Oncology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Jurasz University Hospital 1, Bydgoszcz, Poland
open access
Vol 53, No 3 (2022)
EDITORIAL
Submitted: 2022-05-23
Accepted: 2022-05-23
Abstract
Not available
Abstract
Not available
Get Citation
About this articleTitle
Editorial
Journal
Issue
Article type
Editorial
Pages
151-152
Page views
1846
Article views/downloads
118
DOI
10.5603/AHP.2022.0017
Bibliographic record
Acta Haematol Pol 2022;53(3):151-152.
Authors
Jan Styczyński
References (12)- Styczyński J. Where dreams come true: CAR-T cell therapy in Poland! Acta Haematol Pol. 2020; 51(1): 1.
- Dytfeld D, Łojko-Dankowska A, Matuszak M, et al. Road to clinical implementation of CAR-T technology in Poznań. Acta Haematol Pol. 2020; 51(1): 24–28.
- Marschollek P, Liszka K, Gorczyńska E, et al. A dream that came true: Poland’s first successful CAR-T cell therapy in child with refractory B-cell acute lymphoblastic leukemia (ALL). Acta Haematol Pol. 2021; 52(3): 211–213.
- Styczyński J. A brief history of CAR-T cells: from laboratory to the bedside. Acta Haematol Pol. 2020; 51(1): 2–5.
- Gil L, Łojko-Dankowska A, Matuszak M, et al. CAR-T cell therapy — toxicity and its management. Acta Haematol Pol. 2020; 51(1): 6–10.
- Styczyński J. Infections following CAR-T cells therapy: current state-of-the-art review and recommendations. Acta Haematol Pol. 2020; 51(1): 11–16.
- Bembnista E. Implementation of CAR-T technology into clinical practice: challenge for cell bank. Acta Haematol Pol. 2021; 52: 263–267.
- Dytfeld D, Gil L. Outpatient CAR-T therapy. Acta Haematol Pol. 2022; 53(3): 179–181.
- Gil L, Grajek M. Artificial intelligence and chimeric antigen receptor T-cell therapy. Acta Haematol Pol. 2022; 53(3): 176–179.
- Romejko-Jarosińska J. Radiotherapy in mantle cell lymphoma: a literature review. 2022; 53(3): 166–175.
- Styczyński J, Styczyński T, Sadlok J, et al. Vaccinations following CAR-T cell therapy: summary of reported cases and a state-of-the-art review of the current recommendations. Acta Haematol Pol. 2022; 53(3): 204–212.
- Żyłka K, Dytfeld D, Gil L. Primary refractory mediastinal lymphoma treated with CAR-T: new possibilities and challenges. Acta Haematol Pol. 2022; 53(3): 212–214.